Rayzebio Inc 's

• RYZB's Stock Performance relative to its Competitors

Madrigal Pharmaceuticals Inc Share Performance +0.21% 30 Days

Madrigal Pharmaceuticals Inc Profile Madrigal Pharmaceuticals Inc's business model is focused on developing and commercializing innovative therapeutic solutions for liver diseases, with a particular emphasis on non-alcoholic steatohepatitis (NASH) and other metabolic diseases. They aim to provide effective treatments to address unmet medical needs and improve patient outcomes in these areas. More about Madrigal Pharmaceuticals Inc 's Market Share

Nextcure Inc Share Performance +175.43% This Quarter

Nextcure Inc Profile NextCure Inc is a biopharmaceutical company that operates with a unique business model. They focus on discovering and developing novel immunomedicines to treat various forms of cancer and other immune-related diseases. With a focus on developing innovative therapies that target immune cells, NextCure aims to provide effective and personalized treatment options for patients in need. More about Nextcure Inc 's Market Share

Omeros Corporation Share Performance +100.77% This Quarter

Omeros Corporation Profile Omeros Corporation operates under a business model focused on the research, development, and commercialization of pharmaceutical products. Their core strategy involves leveraging their expertise in biochemistry and pharmacology to identify and target specific therapeutic areas with high unmet medical needs. By conducting clinical trials and seeking regulatory approvals, Omeros aims to bring their innovative products to market and generate revenue through commercial sales. More about Omeros Corporation's Market Share

Oncternal Therapeutics Inc Share Performance -47.74% 30 Days

Oncternal Therapeutics Inc Profile Oncternal Therapeutics Inc's business model focuses on developing and commercializing novel therapies for the treatment of cancer. More about Oncternal Therapeutics Inc 's Market Share

Opko Health Inc Share Performance +14.86% One Year

Opko Health Inc Profile Opko Health Inc is a biotechnology and pharmaceutical company that operates through various business segments. The company primarily focuses on diagnostics, developing and commercializing novel diagnostic tests for various conditions. Additionally, Opko Health engages in the production and sale of pharmaceuticals and vaccines, as well as the research and development of new medical technologies. More about Opko Health Inc 's Market Share

Sources: Rayzebio Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on: Friday, September 18, 2026 6:35 PM
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Rayzebio Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.